Anti-Orai1 antigen binding proteins and uses thereof

Details for Australian Patent Application No. 2010321832 (hide)

Owner Amgen Inc.

Inventors Nguyen, Hung Q.; Lin, Fen-Fen; Bi, Xiao-Juan; McBride, Helen J.; Hu, Shaw-Fen Sylvia

Agent Shelston IP

Pub. Number AU-A-2010321832

PCT Pub. Number WO2011/063277

Priority 61/406,054 22.10.10 US; 61/263,176 20.11.09 US

Filing date 19 November 2010

Wipo publication date 26 May 2011

International Classifications

C07K 14/705 Peptides having more than 20 amino acids

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/06 Drugs for immunological or allergic disorders

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 Hybrid peptides

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/063277 Priority application(s): WO2011/063277

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010321834-Conveyor assembly and dowel assembly

2010321831-7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-N-ethyl-hept-5-enamide (bimatoprost) in crystalline form II, methods for preparation, and methods for use thereof